Ganymede Bio, Inc. — Form D
Ganymede Bio, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-09. The offering totals $15.6M, of which $15.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-08-09
- Form: D
- Accession: 0001940211-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $15.6M
- Amount sold: $15.2M
- Remaining: $440K
- Investors: 14
- Date of first sale: 2022-07-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-455410
Issuer
- Name: Ganymede Bio, Inc.
- CIK: 0001940211
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 3000 EL CAMINO REAL BLDG. 4 SUITE 200, PALO ALTO, CA, 94306
- Phone: 415-409-9768
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Nathan Clark | Director | Palo Alto, CA |
| Varun Gupta | Director | EL SEGUNDO, CA |
| Benson Lee | Director | Palo Alto, CA |
| Nathan Clark | Executive Officer | Palo Alto, CA |
| Benson Lee | Executive Officer | Palo Alto, CA |
More